Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of human SGLT1
Assay data:2 Active, 1 Activity ≤ 1 µM, 2 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of SGLT1 (unknown origin)
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Inhibition of human SGLT1 expressed in CHO cells by methyl-alpha-D-glucopyranoside assay
Assay data:14 Active, 9 Activity ≤ 1 µM, 14 Tested
Inhibition of human SGLT1 expressed in CHO cells assessed as inhibition of [14C] labeled AMG accumulation incubated for 15 mins
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Inhibition of recombinant human SGLT1 expressed in COS-7 cells assessed as inhibition of [14C]AMG uptake
Inhibition of full length N-terminal HA-tagged human SGLT1 expressed in HEK293 cells assessed as inhibition of [14C]AMG uptake
Inhibition of human SGLT1 expressed in HEK293 cell membrane assessed as inhibition of [14C]AMG uptake
Inhibition of human SGLT1 expressed in COS-7 cells
Assay data:2 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of human SGLT1 expressed in CHO-K1 cells
Inhibition of human SGLT1 expressed in xenopus oocytes assessed as inhibition of [14C]AMG uptake
Inhibitory Effect on the Sodium-dependent Glucose Co-Transporter SGLT, SGLT1 and SGLT2 from US Patent USRE49080: "Glycoside derivatives and uses thereof"
Assay data:35 Active, 11 Activity ≤ 1 nM, 35 Activity ≤ 1 µM, 35 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Inhibitory Activity Assay from US Patent US10988462: "Pyrazole compounds substituted with heteroaryl and pharmaceutical use thereof"
Assay data:37 Active, 1 Activity ≤ 1 nM, 37 Activity ≤ 1 µM, 37 Tested
SGLT1/2 in-vitro assay from US Patent US10752604: "C-glucoside derivative containing fused phenyl ring or pharmaceutically acceptable salt thereof, process for preparing same, and pharmaceutical composition comprising same"
Assay data:20 Active, 20 Activity ≤ 1 µM, 20 Tested
Inhibition Assay from US Patent US9505734: "Phenyl C-glucoside derivative containing deoxyglucose structure, preparation method and use thereof"
Assay data:1 Active, 1 Activity ≤ 1 nM, 1 Activity ≤ 1 µM, 1 Tested
SGLT1 Inhibition Assay from US Patent US9340521: "Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives"
Assay data:65 Active, 65 Activity ≤ 1 µM, 65 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
In Vitro Assay from US Patent US9315438: "Optically pure benzyl-4-chlorophenyl-C-glucoside derivative"
Assay data:5 Active, 4 Activity ≤ 1 µM, 5 Tested
Sodium-Dependent Glucose Transporter (SGLT) Assay from US Patent US9296775: "Pyrazole compounds"
Inhibition Assay from US Patent US9161945: "4-isopropyl-6-methoxyphenyl glucitol compound"
Uptake Assay from US Patent US8980829: "Aryl glycoside compound, preparation method and use thereof"
Assay data:25 Active, 25 Activity ≤ 1 µM, 25 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on